According to the authors, the demonstrated ability of TRAIL to induce apoptosis in ovarian cancer cells, as well as to increase the activity of chemotherapeutic agents even in cell lines resistant to TRAIL-induced cytotoxicity, may be of great importance in the fight against this disease [31]. This evidence concerns the gene TNFSF10 and ovarian carcinoma.